University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT02053389
This is an educational intervention study testing the effects of decision aids in promoting patient participation in early stage prostate cancer treatment decision making. The purpose of this study is to compare patient-physician communication between patients who receive a DVD that models patient communication strategies vs. those who do not receive a DVD. All patients will also receive a written decision aid that describes treatment options for early stage prostate cancer. The Investigators hypothesize that the DVD will:
* increase patients' perceptions of the importance of their preferences to their decision making * increase patients' perceptions of their intention to discuss their values and preferences with their urologists and radiation oncologists * increase patients' actual engagement with their physician during the clinical encounter * increase the concordance between patient decision making preferences and actual decision making outcomes * increase long term satisfaction with decision on type of treatment selected * increase patient satisfaction with their decision and the decision making process * influence patient perception of his physician (e.g., trust) and of the diagnosis visit
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The decision aid, "Discussing the Choice: Talking with your Doctor about Early Stage Prostate Cancer" is a DVD modeling patient communication strategies. The DVD includes vignettes with actors depicting patient-physician discussions of prostate cancer treatments. In these vignettes, the patient models communication strategies designed to facilitate patient activation.
A written decision aid entitled "Making the Choice: Deciding What to Do About Early Stage Prostate Cancer" that describes treatment options for early stage prostate cancer.
Time frame: Time 1 (baseline)
14 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
14 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
14 item survey instrument
Time frame: Time 1 (baseline)
1 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
1 item survey instrument
Time frame: Time 1 (baseline)
10 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
10 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
12 item survey instrument
Time frame: Time 1 (baseline)
6 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
6 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
6 item survey instrument
Time frame: Time 4 (6 months post diagnosis)
7 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
1 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
2 item survey instrument
Time frame: Time 4 (6 months post diagnosis)
2 item survey instrument
Time frame: Time 4 (6 months post diagnosis)
5 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
1 item survey instrument
Time frame: Time 4 (6 months post diagnosis)
1 item survey instrument
University of Michigan
Other
Promoting Shared Decision Making in Prostate Cancer Through Decision Aids
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04108208
Genital Diseases, Genital Diseases, Male
Beijing, China
View Trial DetailsNCT03834493
Genital Diseases, Genital Diseases, Male
Mobile, Alabama, United States
View Trial DetailsNCT02854982
Genital Diseases, Genital Diseases, Male
Nîmes, Gard, France
View Trial DetailsNCT03421015
Disease Attributes, Genital Diseases
Lille, France
View Trial Details